Navigation Links
Kantar Health Uncovers Opportunities and Challenges for Biosimilars in Asia
Date:11/11/2013

New York, NY (PRWEB) November 12, 2013

Kantar Health, a leading global healthcare consulting firm, will release new details on biosimilar opportunities and challenges for pharmaceutical manufacturers in Asia at the EphMRA 2013 Asia Conference on November 14 in Singapore. Questa Lin, General Manager, Taiwan, and Simon Li, General Manager, China, will present.

In their presentation, “Uncover Biosimilars Opportunities and Challenges – Utilising Market Insights,” Ms. Lin and Mr. Li will provide a comprehensive understanding of the opportunities and barriers for developing biosimilars, how to apply market access strategies, and the research required to produce forecasting estimates.

In addition, Alice Lee, Regional Talent Director at Kantar Health, will participate in the panel discussion “Talent Management Issues” on November 13, which will focus on challenges in recruiting and retaining market researchers.

Kantar Health is a Silver Sponsor of the EphMRA 2013 Asia Conference. More information on this event can be found at http://www.ephmra.org/events/2013-asia-conference.aspx.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11319731.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patients Experience Impairments Just One Year After Knee Replacement Surgery, According to New Kantar Health Research
2. Kantar Health to Highlight Strategies for Accessing U.S. and EU Markets for Japan Pharma
3. Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
4. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
5. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
6. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
7. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
8. Kantar Health Launches CancerMPact Biomarker Analysis
9. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
10. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
11. Kantar Health to Present at PBIRG Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... ... On Saturday, October 21, the Health & Wellness Center at Florida Hospital ... for the American Heart Association Heart Walk. Teams of up to 10 people can ... their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on Saturday, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: